Nothing said here yet.
to join the conversation.
| Britt Lisa P.Sr. VP and Chief HR Officer | Sell | 2,831 | $2.0M | Wed, Oct 28 |
| Pettiti GianlucaPresident & COO | Sell | 3,733 | $2.3M | Mon, Aug 31 |
| Pettiti GianlucaPresident & COO | Sell | 400 | $245.8K | Mon, Aug 31 |
| CASPER MARC NChairman & CEO | Sell | 101 | $63.2K | Mon, Aug 24 |
| CASPER MARC NChairman & CEO | Sell | 79 | $49.6K | Mon, Aug 24 |
| CASPER MARC NChairman & CEO | Sell | 62 | $39.0K | Mon, Aug 24 |
| CASPER MARC NChairman & CEO | Sell | 33 | $20.7K | Mon, Aug 24 |
| CASPER MARC NChairman & CEO | Sell | 3,014 | $1.9M | Fri, Aug 21 |
| CASPER MARC NChairman & CEO | Sell | 2,727 | $1.7M | Fri, Aug 21 |
| CASPER MARC NChairman & CEO | Sell | 2,147 | $1.3M | Fri, Aug 21 |
| CASPER MARC NChairman & CEO | Sell | 1,791 | $1.1M | Fri, Aug 21 |
| CASPER MARC NChairman & CEO | Sell | 321 | $201.9K | Fri, Aug 21 |
| Alan Armstrong | Buy | $8.0K | Fri, Mar 27 | Tue, Jul 21 |
| Dan Newhouse | Sell | $8.0K | Fri, Jul 10 | Fri, Jul 10 |
| Dwight Evans | Sell | $8.0K | Thu, May 7 | Thu, May 14 |
| Michael Rulli | Sell | $8.0K | Thu, Dec 12 | Thu, Dec 12 |
The fair value estimate for Thermo Fisher Scientific has shifted from US$686.64 to US$750.92, giving investors an updated anchor for thinking about the stock.
Thermo Fisher Scientific reported past third quarter 2026 results with sales of US$12.137b and net income of US$1.721b, with earnings per share from continuing operations modestly higher than a year earlier on both a basic and diluted basis.
Players: Roche, Thermo Fisher, IQVIA, Labcorp, Eurofins. Profiled: gene-panel design, harmonization, interpretation, reporting, technologies, applications and regions.Dublin, Oct.
Profiles Roche, Thermo Fisher, Eurofins, Agilent and Illumina, covering bead-linked transposase kits for streamlined DNA/RNA sequencing-library preparationDublin, Oct.
Dublin, Oct. 29, 2026 (GLOBE NEWSWIRE) -- "Synthetic Gene Circuits Global Market Report 2026" has been added to ResearchAndMarkets.com's offering.
Viral Genome Sequencing Market to Reach $13.57 Billion by 2030 as Genomic Surveillance ExpandsDublin, Oct. 29, 2026 (GLOBE NEWSWIRE) -- "Viral Genome Sequencing Global Market Report 2026" has been added to ResearchAndMarkets.com's offering.
Boost ROI with long-read sequencing, AI, cloud bioinformatics and custom pipelines; target clinical and agricultural microbiomes while localizing infrastructure and diversifying suppliers.Dublin, Oct.
Boost ROI via AI interpretation, EHR integration, expanded screening, personalized prevention, and local manufacturing to offset tariffs.Dublin, Oct.
Thermo Fisher Scientific (NYSE:TMO) has been highlighted as a leading player in the cell and gene therapy CRO market.
Thermo Fisher Scientific (TMO) released third quarter 2026 results that showed sales of US$12.1b and net income of US$1.7b. These figures frame how the stock’s recent move might be interpreted.
Thermo Fisher Scientific has delivered a strong share-price run in recent years, and that kind of climb naturally raises a question for you as an investor.
Dublin, Oct. 28, 2026 (GLOBE NEWSWIRE) -- "Custom Recombinant Protein Production Services Market Report 2026" has been added to ResearchAndMarkets.com's offering.